201 related articles for article (PubMed ID: 34149712)
1. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
Front Immunol; 2021; 12():676679. PubMed ID: 34149712
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.
Semple PL; Binder AB; Davids M; Maredza A; van Zyl-Smit RN; Dheda K
Am J Respir Crit Care Med; 2013 Jun; 187(11):1249-58. PubMed ID: 23590266
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ decreased the suppressive function of CD33
Zhan X; Hu S; Wu Y; Li M; Liu T; Ming S; Wu M; Liu M; Huang X
Mol Immunol; 2018 Feb; 94():107-120. PubMed ID: 29291452
[TBL] [Abstract][Full Text] [Related]
5. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive role of CD11b
Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
[TBL] [Abstract][Full Text] [Related]
7. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
[TBL] [Abstract][Full Text] [Related]
8. IL-4 subverts mycobacterial containment in
Pooran A; Davids M; Nel A; Shoko A; Blackburn J; Dheda K
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31097521
[TBL] [Abstract][Full Text] [Related]
9. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
Balfour A; Schutz C; Goliath R; Wilkinson KA; Sayed S; Sossen B; Kanyik JP; Ward A; Ndzhukule R; Gela A; Lewinsohn DM; Lewinsohn DA; Meintjes G; Shey M
Front Immunol; 2021; 12():648216. PubMed ID: 33828558
[No Abstract] [Full Text] [Related]
10. TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494.
Moaaz M; Lotfy H; Elsherbini B; Motawea MA; Fadali G
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3393-3403. PubMed ID: 33247701
[TBL] [Abstract][Full Text] [Related]
11. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
Front Immunol; 2021; 12():594376. PubMed ID: 33981297
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
13. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
14. CD14
Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T Cells Subvert Mycobacterial Containment in Patients Failing Extensively Drug-Resistant Tuberculosis Treatment.
Davids M; Pooran AS; Pietersen E; Wainwright HC; Binder A; Warren R; Dheda K
Am J Respir Crit Care Med; 2018 Jul; 198(1):104-116. PubMed ID: 29425052
[TBL] [Abstract][Full Text] [Related]
16. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
[TBL] [Abstract][Full Text] [Related]
17. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
20. Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis.
Leukes VN; Dorhoi A; Malherbe ST; Maasdorp E; Khoury J; McAnda S; Walzl G; du Plessis N
Cell Immunol; 2021 Jun; 364():104359. PubMed ID: 33865151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
